Josh Copp is a medical technology executive, investor and prior management consultant. He most recently was with Ceribell, a medical device venture in the Bay Area commercializing a point-of-care EEG system that makes the diagnosis of neurological patients drastically more efficient. Prior to Ceribell, Josh was a partner at McKinsey & Company, based out of their San Francisco office. With McKinsey, Josh primarily worked with clients in the medical products sector, focused on corporate strategy, growth strategy, transactions, commercial effectiveness and R&D effectiveness. Before McKinsey he was an analyst with BCG ValueScience out of San Francisco. Josh received an AB from Harvard University in Applied Mathematics and an MBA from MIT’s Sloan School of Business.

Josh has maintained a passion for the ocean his entire life, growing up surfing in San Diego and never living farther than 10 miles from the ocean. Josh started serving on The Marine Mammal Center’s Board in 2016 and focuses much of his time supporting the Center’s strategic initiatives and operations. He currently serves as the Vice Chair of the Board and on the Cabinet for the Center’s Comprehensive Campaign. He is currently raising two children with his wife, Aline, and their dog, Obi, and makes frequent trips into the Marin headlands to observe The Marine Mammal Center’s patients.